A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP in Uninfected Adult Volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs VRC-HIVDNA009-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 04 Nov 2005 New trial record.